| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Spp1 ELISA Kit; 2b7 ELISA Kit; Spp-1 ELISA Kit; Osteopontin ELISA Kit; Bone sialoprotein 1 ELISA Kit; Secreted phosphoprotein 1 ELISA Kit; SPP-1 ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, tissue homogenates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
Osteopontin (SPP1) is a biological molecule commonly studied in metabolism research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P08721
Biological context
Researchers often monitor Osteopontin in serum, plasma, and tissue homogenates to better understand themes such as energy homeostasis, glucose and lipid metabolism, and insulin sensitivity and endocrine regulation. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in Osteopontin may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, insulin, adipokines, lipid-transport proteins, and stress-related enzymes) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, Osteopontin may also appear under names such as Spp1 and 2b7. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Osteopontin participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Serum biomarkers of isoniazid‐induced liver injury: Aminotransferases are insufficient, and OPN, L‐FABP and HMGB1 can be promising novel biomarkers
X Cheng,Journal of applied toxicology,2023
Hydroxycitrate prevents calcium oxalate crystallization and kidney injury in a nephrolithiasis rat model
Bowei Yang,Urolithiasis,2021
Arginine based poly (ester amide)/ hyaluronic acid hybrid hydrogels for bone tissue Engineering
Yang Zhou, et al,Carbohydrate Polymers,2019
Mesalazine, an osteopontin inhibitor: The potential prophylactic and remedial roles in induced liver fibrosis in rats
A.Ramadan.et al,Chemico-Biological Interactions,2018
Psoralidin, a prenylated coumestan, as a novel anti-osteoporosis candidate to enhance bone formation of osteoblasts andDecrease bone resorption of osteoclasts
Yuankun Zhai.et al,European Journal of Pharmacology,2017
Polycystic Ovary Syndrome is Associated with Increased Osteopontin Levels
Saklamaz A. et al,Eur J Endocrinol,2015
Pro-inflammatory cytokines induce odontogenic differentiation of dental pulp-derived stem cells
Xuechao Yang et al,Journal of cellular biochemistry,2012
Effect of biomimetic 3D environment of an injectable polymeric scaffold on MG-63 osteoblastic-cell response
Shalini Verma et al,Materials science & engineering ,2010